BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2020 10:32:14 AM | Browse: 827 | Download: 1181
 |
Received |
|
2019-12-30 14:08 |
|
Peer-Review Started |
|
2019-12-30 14:13 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-02-20 06:07 |
|
Revised |
|
2020-03-25 23:54 |
|
Second Decision |
|
2020-03-27 07:59 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-03-30 01:42 |
|
Articles in Press |
|
2020-03-30 01:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-04-22 06:13 |
|
Publish the Manuscript Online |
|
2020-04-22 10:32 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Review |
| Article Title |
Narrowing the focus: Therapeutic cell surface targets for refractory triple-negative breast cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Narges K Tafreshi, David L Morse and Marie Catherine Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marie Catherine Lee, FACS, MD, Surgeon, Surgical Oncologist, Comprehensive Breast Program, Moffitt Cancer Center, 12920 N. McKinley Drive, Tampa, FL 33612, United States. m.catherine.lee@moffitt.org |
| Key Words |
Breast cancer; Triple negative; Biomarker; Cell surface; Targeted therapy; Chemorefractory |
| Core Tip |
Triple-negative breast cancer continues to be a challenge in breast cancer therapeutics, as these heterogeneous tumors are refractory to many effective and well-tolerated standard treatments. Even more concerning is the subpopulation of these tumors that progress even on the most aggressive therapeutic regimens. The core of this work reviews the developing approaches for treatment-refractory triple-negative breast cancer and proposes cell-surface targeting as a novel modality for targeted treatment of resistant disease. |
| Publish Date |
2020-04-22 10:32 |
| Citation |
Tafreshi NK, Morse DL, Lee MC. Narrowing the focus: Therapeutic cell surface targets for refractory triple-negative breast cancer. World J Clin Oncol 2020; 11(4): 169-179 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i4/169.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i4.169 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
